# SUBVENITE
> **NDA218879** · New Drug Application · Sponsor: OWP PHARMS · Approved 2025-09-16
## Drug
- **FDA Application Number:** NDA218879
- **Application type:** New Drug Application
- **Brand name:** SUBVENITE
- **Generic name:** LAMOTRIGINE
- **Active ingredients:** LAMOTRIGINE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** OWP PHARMS
- **Manufacturer:** OWP Pharmaceuticals, Inc.
- **First approval:** 2025-09-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218879)
---
*AI Analytics · CC0 1.0*